Antibody Response to Severe Acute Respiratory Syndrome-Coronavirus-2 Messenger RNA Vaccines in Liver Transplant Recipients
Liver Transpl
.
2021 Dec;27(12):1852-1856.
doi: 10.1002/lt.26273.
Epub 2021 Sep 16.
Authors
Alexandra T Strauss
1
,
Andrew M Hallett
2
,
Brian J Boyarsky
2
,
Michael T Ou
2
,
William A Werbel
1
,
Robin K Avery
1
,
Aaron A R Tobian
3
4
,
Allan B Massie
2
,
James P A Hamilton
1
,
Jacqueline M Garonzik-Wang
2
,
Dorry L Segev
2
4
Affiliations
1
Department of MedicineJohns Hopkins University School of MedicineBaltimoreMD.
2
Department of SurgeryJohns Hopkins University School of MedicineBaltimoreMD.
3
Department of PathologyJohns Hopkins University School of MedicineBaltimoreMD.
4
Department of EpidemiologyJohns Hopkins University School of MedicineBaltimoreMD.
PMID:
34407309
PMCID:
PMC8441851
DOI:
10.1002/lt.26273
No abstract available
Publication types
Research Support, N.I.H., Extramural
MeSH terms
Antibody Formation
COVID-19*
Humans
Liver Transplantation*
SARS-CoV-2
Transplant Recipients
Grants and funding
K23DK115908/DK/NIDDK NIH HHS/United States
T32 DK007732/DK/NIDDK NIH HHS/United States
T32DK007732/DK/NIDDK NIH HHS/United States
K24 AI144954/AI/NIAID NIH HHS/United States
F32DK124941/DK/NIDDK NIH HHS/United States
T32 DK007713/DK/NIDDK NIH HHS/United States
K01DK101677/DK/NIDDK NIH HHS/United States